Impact of Preoperative Intravitreal Anti-VEGF on Vitrectomy for  Proliferative Diabetic Retinopathy: A Prospective Study

Arif Ullah, Sidra Zafar, Usama Javaid, Aneeb Ashraf, Tahir Mahmood Khan, Saadullah Ahmad

Impact of Preoperative Intravitreal Anti-VEGF on Vitrectomy for Proliferative Diabetic Retinopathy: A Prospective Study

Authors

Arif Ullah, Sidra Zafar, Usama Javaid, Aneeb Ashraf, Tahir Mahmood Khan, Saadullah Ahmad

Keywords:

Proliferative Diabetic Retinopathy, Anti-VEGF, Vitrectomy

Abstract

Proliferative diabetic retinopathy (PDR)remains a major cause of vision lossworldwide, primarily due to fibrovascular
proliferationandvitreoushemorrhagerequiring pars plana vitrectomy (PPV). Thepresent prospective interventional study

References

Smith AJ, et al. Outcomes of pars plana vitrectomy in diabetic retinopathy. Retina. 2022;42(3):455–463.

Brown DM, et al. VEGF inhibition in diabetic retinal disease. Ophthalmology. 2023;130(2):112–120.

Downloads

Published

2026-05-05

How to Cite

Arif Ullah, Sidra Zafar, Usama Javaid, Aneeb Ashraf, Tahir Mahmood Khan, Saadullah Ahmad. (2026). Impact of Preoperative Intravitreal Anti-VEGF on Vitrectomy for Proliferative Diabetic Retinopathy: A Prospective Study. International Journal of Pharmacy Research & Technology (IJPRT), 16(1), 2120–2125. Retrieved from https://ijprt.org/index.php/pub/article/view/1840